Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 2
1985 2
1986 4
1987 1
1988 7
1989 2
1990 3
1991 4
1992 2
1993 1
1994 2
1999 1
2000 1
2001 1
2005 1
2006 1
2007 2
2008 1
2009 1
2012 1
2014 1
2016 1
2017 2
2018 1
2019 1
2021 2
2022 1
2023 0
Text availability
Article attribute
Article type
Publication date

Search Results

47 results
Results by year
Filters applied: . Clear all
Page 1
Butoconazole nitrate.
Tatum DM, Eggleston M. Tatum DM, et al. Infect Control Hosp Epidemiol. 1988 Mar;9(3):122-4. doi: 10.1086/645809. Infect Control Hosp Epidemiol. 1988. PMID: 3280665 Clinical Trial. No abstract available.
Comparison of three-day butoconazole treatment with seven-day miconazole treatment for vulvovaginal candidiasis.
Kaufman RH, Henzl MR, Brown D Jr, Horner DS, Krauss RH, Mehlisch DR, Moore DE, Prentice RL. Kaufman RH, et al. J Reprod Med. 1989 Jul;34(7):479-83. J Reprod Med. 1989. PMID: 2671362 Clinical Trial.
Eight to ten days after treatment completion, 88% of the butoconazole-treated patients and 91% of the miconazole-treated patients were Candida negative; 80% of the butoconazole-treated patients and 82% of the miconazole-treated patients were considered clinically cu …
Eight to ten days after treatment completion, 88% of the butoconazole-treated patients and 91% of the miconazole-treated patients wer …
An evaluation of butoconazole nitrate 2% site release vaginal cream (Gynazole-1) compared to fluconazole 150 mg tablets (Diflucan) in the time to relief of symptoms in patients with vulvovaginal candidiasis.
Seidman LS, Skokos CK. Seidman LS, et al. Infect Dis Obstet Gynecol. 2005 Dec;13(4):197-206. doi: 10.1080/10647440500240615. Infect Dis Obstet Gynecol. 2005. PMID: 16338779 Free PMC article. Clinical Trial.

RESULTS: The median time to first relief of symptoms occurred at 17.5 h for butoconazole patients as compared to 22.9 h for fluconazole patients (p < 0.001). The time at which 75% of patients experienced first relief of symptoms was 24.5 h versus 46.3 h for butoconaz

RESULTS: The median time to first relief of symptoms occurred at 17.5 h for butoconazole patients as compared to 22.9 h for fluconazo …
Butoconazole nitrate 2% for vulvovaginal candidiasis. New, single-dose vaginal cream formulation vs. seven-day treatment with miconazole nitrate. Gynazole 1 Study Group.
Brown D, Henzl MR, Kaufman RH. Brown D, et al. J Reprod Med. 1999 Nov;44(11):933-8. J Reprod Med. 1999. PMID: 10589403 Clinical Trial.
OBJECTIVE: To compare the safety and efficacy of a single vaginal dose of a butoconazole nitrate 2% bioadhesive, sustained-release cream* (butoconazole 1-BSR) with a seven-day schedule of miconazole nitrate vaginal cream 2% (miconazole 7). ...A total of 205 patients …
OBJECTIVE: To compare the safety and efficacy of a single vaginal dose of a butoconazole nitrate 2% bioadhesive, sustained-release cr …
Three-day treatment of vulvovaginal candidiasis.
Adamson GD. Adamson GD. Am J Obstet Gynecol. 1988 Apr;158(4):1002-5. doi: 10.1016/0002-9378(88)90114-7. Am J Obstet Gynecol. 1988. PMID: 3364485
Butoconazole nitrate, a newer imidazole, is effective for the treatment of vulvovaginal candidiasis when administered as a vaginal cream. ...The suppository form of butoconazole may offer a valuable therapeutic alternative for patients who wish to use it instead of
Butoconazole nitrate, a newer imidazole, is effective for the treatment of vulvovaginal candidiasis when administered as a vaginal cr
Development of a liquid chromatography-tandem mass spectrometry method for determination of butoconazole nitrate in human plasma and its application to a pharmacokinetic study.
Jia MM, Zhou Y, He XM, Wu YL, Li HQ, Chen H, Li WY. Jia MM, et al. J Huazhong Univ Sci Technolog Med Sci. 2014 Jun;34(3):431-436. doi: 10.1007/s11596-014-1296-y. Epub 2014 Jun 18. J Huazhong Univ Sci Technolog Med Sci. 2014. PMID: 24939312
The compounds were eluted isocratically on an Inertsil ODS-SP column (100 mm2.1 mm, 3 mum), ionized using a positive ion atmospheric pressure electrospray ionization source and analyzed using multiple reaction monitoring (MRM) mode. The ion transitions monitored were m/z 412.8165 …
The compounds were eluted isocratically on an Inertsil ODS-SP column (100 mm2.1 mm, 3 mum), ionized using a positive ion atmospheric pressur …
Three-day treatment with butoconazole nitrate for vulvovaginal candidiasis.
Droegemueller W, Adamson DG, Brown D, Cibley L, Fleury F, LePage ME, Henzl MR. Droegemueller W, et al. Obstet Gynecol. 1984 Oct;64(4):530-4. Obstet Gynecol. 1984. PMID: 6384848 Clinical Trial.
A multicenter clinical trial of 274 patients compared the efficacy and safety of a new vaginal antifungal compound, butoconazole nitrate cream 2% (butoconazole), to clotrimazole vaginal tablets 200 mg/day (clotrimazole). ...Complete absence of the entrance signs and …
A multicenter clinical trial of 274 patients compared the efficacy and safety of a new vaginal antifungal compound, butoconazole nitr …
Control of Candida albicans vaginitis in mice by short-duration butoconazole treatment in situ.
Valentin A, Bernard C, Mallié M, Huerre M, Bastide JM. Valentin A, et al. Mycoses. 1993 Nov-Dec;36(11-12):379-84. doi: 10.1111/j.1439-0507.1993.tb00726.x. Mycoses. 1993. PMID: 7935569
Treatment consisted of butoconazole solutions (1%, 2.5% and 5%) administered intravaginally. ...For each treatment, a remission of 10-15 days was observed, but was followed by a recurrence for the lower dose of butoconazole; only the higher butoconazole conce …
Treatment consisted of butoconazole solutions (1%, 2.5% and 5%) administered intravaginally. ...For each treatment, a remission of 10 …
Treatment of recurrent vulvo-vaginal candidiasis with sustained-released butoconazole pessary.
Heng LZ, Chen Y, Tan TC. Heng LZ, et al. Singapore Med J. 2012 Dec;53(12):e269-71. Singapore Med J. 2012. PMID: 23268172 Free article.
This could be due to patient factors, drug application (such as leakage) or dosing factors. A sustained-release (SR) bioadhesive vaginal cream (2% butoconazole nitrate) has incorporated VagiSite technology, a topical drug delivery system that allows SR of the drug. We desc …
This could be due to patient factors, drug application (such as leakage) or dosing factors. A sustained-release (SR) bioadhesive vaginal cre …
47 results